Research interests include Vascular Malformations and Hemangiomas, Vascular Tumors and Angiosarcomas, Tumors and Oncological Cases, and Cancer, Hypoxia, and Metabolism.
Safety, bactericidal activity, and pharmacokinetics of the antituberculosis drug candidate BTZ-043 in South Africa (PanACEA-BTZ-043–02): an open-label, dose-expansion, randomised, controlled, phase 1b/2a trial
The Lancet Microbe2025cited by 23position: middledoi
Cross-modal deep learning model for predicting pathologic complete response to neoadjuvant chemotherapy in breast cancer
npj Precision Oncology2024cited by 19position: middledoi